Search Results - "Waidmann, O"

Proton pump inhibitor treatment is associated with the severity of liver disease and increased mortality in patients with cirrhosis by Dultz, G., Piiper, A., Zeuzem, S., Kronenberger, B., Waidmann, O.

“…Summary Background Proton pump inhibitors (PPI) are widely used in patients with liver diseases. Within the last years, there have been concerns about the PPI…”
Get full text

Severe 25‐hydroxyvitamin D deficiency identifies a poor prognosis in patients with hepatocellular carcinoma – a prospective cohort study by Finkelmeier, F., Kronenberger, B., Köberle, V., Bojunga, J., Zeuzem, S., Trojan, J., Piiper, A., Waidmann, O.

“…Summary Background Vitamin D is involved in many biological processes. The role of vitamin D in patients with hepatocellular carcinoma (HCC) remains…”
Get full text

Serum microRNA-122 levels in different groups of patients with chronic hepatitis B virus infection by Waidmann, O., Bihrer, V., Pleli, T., Farnik, H., Berger, A., Zeuzem, S., Kronenberger, B., Piiper, A.

“…miR‐122 is a liver‐specific microRNA, which also circulates in the blood. The levels of miR‐122 in serum and plasma correlate with hepatic necroinflammation in…”
Get full text

The macrophage activation marker CD163 is associated with IL28B genotype and hepatic inflammation in chronic hepatitis C virus infected patients by Dultz, G., Gerber, L., Zeuzem, S., Sarrazin, C., Waidmann, O.

“…Summary Recent data highlighted the association of the macrophage activation marker CD163 with histological inflammation and fibrosis in chronic hepatitis C…”
Get full text

Mismatch repair deficiency, chemotherapy and survival for resectable gastric cancer: an observational study from the German staR cohort and a meta-analysis by Stolze, T., Franke, S., Haybaeck, J., Moehler, M., Grimminger, P. P., Lang, H., Roth, W., Gockel, I., Kreuser, N., Bläker, H., Wittekind, C., Lordick, F., Vieth, M., Veits, L., Waidmann, O., Lingohr, P., Peitz, U., Schildberg, C., Kruschewski, M., Vassos, N., Goni, E., Bruns, C. J., Ridwelski, K., Wolff, S., Lippert, H., Schumacher, J., Malfertheiner, P., Venerito, M.

“…Purpose In a post hoc analysis of the MAGIC trial, patients with curatively resected gastric cancer (GC) and mismatch repair (MMR) deficiency (MMRd) had better…”
Get full text

P0189 : Proton Pump Inhibitor treatment is associated with increased mortality in patients with cirrhosis by Dultz, G, Piiper, A, Zeuzem, S, Kronenberger, B, Waidmann, O

Get full text

P0194 : Severe 25-hydroxyvitamin D deficiency is associated with infections and mortality in cirrhosis by Finkelmeier, F, Kronenberger, B, Zeuzem, S, Piiper, A, Waidmann, O

Get full text

Letter: proton pump inhibitors ‐ severity of liver disease and mortality in patients with cirrhosis – authors' reply by Dultz, G., Piiper, A., Zeuzem, S., Kronenberger, B., Waidmann, O.

Get full text

Letter: proton pump inhibitor treatment and increased mortality in cirrhotic patients – authors' reply by Dultz, G., Piiper, A., Zeuzem, S., Kronenberger, B., Waidmann, O.

Get full text

Efficacy of Treatment Using Direct Acting Antiviral Drugs (DAAS) in Hepatitis C Virus-Infected Patients with Hepatocellular Carcinoma – Real Life Data by Waidmann, O, Welker, M.-W, Weiler, N, Zeuzem, S, Sarrazin, C, Vermehren, J

Get full text

The impact of carbapenem resistance on clinical deterioration and mortality in patients with liver disease by Ferstl, P.G, Filmann, N, Brandt, C, Zeuzem, S, Hogardt, M, Kempf, V.A, Müller, M, Waidmann, O, Reinheimer, C

Get full text

Hepatocellular carcinoma recurrence after direct antiviral agent treatment: a european multicentric study by Kolly, P, Waidmann, O, Vermehren, J, Moreno, C, Berg, T, Semela, D, Zeuzem, S, Dufour, J.-F

Get full text

Soluble CD163 is an indicator of liver inflammation and fibrosis in patients chronically infected with the hepatitis B virus by Dultz, G., Gerber, L., Farnik, H., Berger, A., Vermehren, J., Pleli, T., Zeuzem, S., Piiper, A., Kronenberger, B., Waidmann, O.

“…Summary Soluble CD163 (sCD163), a marker for macrophage activation, was found to be associated with the severity of liver cirrhosis. The aim of the current…”
Get full text

Serum microRNA-122 kinetics in patients with chronic hepatitis C virus infection during antiviral therapy by Köberle, V., Waidmann, O., Kronenberger, B., Andrei, A., Susser, S., Füller, C., Perner, D., Zeuzem, S., Sarrazin, C., Piiper, A.

“…Summary The levels of the liver‐specific microRNA‐122 (miR‐122) circulating extracellularly in the blood have been shown to be increased upon liver damage…”
Get full text

Quality of life (QoL) in patients with metastatic pancreatic cancer receiving first-line Nab-paclitaxel/gemcitabine chemotherapy: Results of the large QoL study AIO-QoliXane/PARAGON by Schönherr, C., Götze, T.O., zur Hausen, G., Reichart, A., Pauligk, C., Schlag, R., Siegler, G.M., Dörfel, S., Aldaoud, A., Hahn, L., Schubert, J., Zahn, M.-O., Höffkes, H.-G., Reiser, M., Koenigsmann, M., Blau, W., Waidmann, O., Homann, N., Trojan, J., Al-Batran, S.-E.

Get full text

Inhibition of the oncoprotein FUBP1 by SN-38 represents a novel therapeutic option for the treatment of hepatocellular carcinoma by Hauck, S, Khageh Hosseini, S, Wesely, J, Trojan, J, Gerlach, K, Schulze, J, Hahn, S, Steinhilber, D, Gatterdam, V, Zeuzem, S, Waidmann, O, Zangos, S, Biondi, R, Proschak, E, Zörnig, M

“…An abstract of a study by Hauck et al on the inhibition of oncoprotein FUSE Binding Protein 1 (FUBPI) by SN-38 representing a novel therapeutic option for the…”
Get full text

625 MACROPHAGE ACTIVATION IS A PROGNOSTIC PARAMETER FOR VARICEAL BLEEDING AND OVERALL SURVIVAL IN PATIENTS WITH LIVER CIRRHOSIS by Waidmann, O, Brunner, F, Zeuzem, S, Piiper, A, Kronenberger, B

Get full text

P483 CK 18 BASED SERUM APOPTOTIC CELL DEATH MARKER M30 PREDICTS SURVIVAL IN PATIENTS WITH LIVER CIRRHOSIS by Waidmann, O, Brunner, F, Herrmann, E, Zeuzem, S, Piiper, A, Kronenberger, B

Get full text

Prognosis and tumor biology of pancreatic cancer patients with isolated lung metastases: translational results from the German multicenter AIO-YMO-PAK-0515 study by Kruger, S.F., Lohneis, A., Abendroth, A., Berger, A.W., Ettrich, T.J., Waidmann, O., Kapp, M., Steiner, B., Kumbrink, J., Reischer, A., Haas, M., Westphalen, C.B., Zhang, D., Miller-Phillips, L., Burger, P.J., Kobold, S., Werner, J., Subklewe, M., von Bergwelt-Baildon, M., Kunzmann, V., Seufferlein, T., Siveke, J.T., Sinn, M., Heinemann, V., Ormanns, S., Boeck, S.

“…Pulmonary metastasis (M1-PUL) as first site of dissemination in pancreatic ductal adenocarcinoma (PDAC) is a rare event and may define a distinct biological…”
Get full text

P0335 : Serum long chain ceramides, sphingosine and sphingosine-1-phosphate as novel diagnostic markers in patients with hepatocellular carcinoma by Grammatikos, G, Schoell, N, Ferreiros, N, Bon, D, Herrmann, E, Farnik, H, Zeuzem, S, Kronenberger, B, Waidmann, O, Pfeilschifter, J

Get full text